EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn’s Disease

Giulia D'Arcangelo, Delia De Mitri, Ludovica Busato, Lorenza Bottino, Francesca Maccioni, Andrea Verrino, Marina Aloi iD

Inflammatory Bowel Diseases · 2026

DOI: 10.1093/ibd/izaf193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Giulia D'Arcangelo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Sarcopenia, Crohn Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The effect of sarcopenia on clinical outcomes in children with Crohn’s disease (CD) is unknown. We investigated whether sarcopenia at the diagnosis impacts the outcomes of children with CD.

Methods

This was a retrospective, single-center, case-control study of newly diagnosed children with CD undergoing magnetic resonance (MR) within 1 month from the diagnosis, from 2011 to 2022. Sarcopenia was assessed by measuring total psoas muscle area (tPMA) at L3-L4 level on the MR and defined as z-score values ≤2 SDs. Children with and without sarcopenia were compared for the risk of disease flares, CD-related hospitalization, complications, need for step-up treatment, and courses of steroids over a 2-year follow-up.

Results

Seventy-eight children were included (median age 10.7 years), 46 (59%) with sarcopenia and 32 (41%) without. The risk of clinical relapse was higher in patients with sarcopenia at 6 [19.5% vs 3%, odds ratio (OR) 7.5 (95% CI, 1.5-85)] and 12 months [30% vs 6%, OR 6.5 (95% CI, 1.4-30.4)]. Kaplan-Meier analysis showed lower survival free from relapses in children with sarcopenia (log rank P = .01, hazard ratio 2.7, 95% CI, 1.4-4.5). Multivariate analysis identified sarcopenia as independent predictors of clinical relapses (OR 1.7, 95% CI, 1-3.1, P = .045). No other independent predictor of unfavorable outcome was detected.

Conclusions

The presence of sarcopenia at the diagnosis increases the risk of clinical relapses in the first year of diagnosis. Magnetic resonance evaluation of the tPMA could therefore help identify children at higher risk of worse outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaCrohn DiseaseHumansMaleFemaleChildRetrospective StudiesCase-Control StudiesMagnetic Resonance ImagingAdolescentPrognosisRecurrencePsoas MusclesFollow-Up StudiesHospitalizationKaplan-Meier Estimate

Stichwörter der Autor:innen

Crohn's diseasebody compositionchildrenmuscle mass

Autor:innen und Institutionen

  • Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy.
  • Pediatric Gastroenterology, Hepatology and Cystic Fibrosis Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano, Milan, Italy.
  • Department of Radiology, Sapienza University of Rome, Rome, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

ORCID-Profile: Marina Aloi

Zitieren

APA

D'Arcangelo, G., De Mitri, D., Busato, L., Bottino, L., Maccioni, F., Verrino, A., & Aloi, M. (2026). The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn’s Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf193

Vancouver

D'Arcangelo G, De Mitri D, Busato L, Bottino L, Maccioni F, Verrino A, et al. The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn’s Disease. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf193

BibTeX
@article{DArcangelo2026,
  author = {D'Arcangelo, Giulia and De Mitri, Delia and Busato, Ludovica and Bottino, Lorenza and Maccioni, Francesca and Verrino, Andrea and Aloi, Marina},
  title = {The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn’s Disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izaf193}
}
Kostenlos starten →